在阻塞性睡眠呼吸暂停中,急性间歇性缺氧和间歇性穿皮电刺激的结合:一种随机对照交叉试验
Shiqian Zha1, Xu Liu1, Hao Chen1
1Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Respiratory physiology & neurobiology
|June 17, 2024
概括
间歇性缺氧 (IH) 和间歇性穿皮电刺激 (ITES) 显著降低了阻塞性睡眠呼吸暂停 (OSA) 的严重程度. 虽然IH&ITES在轻度至中度的OSA中显示出比IH更好的疗效,但它与ITES相比,不支持其对ITES的建议.
科学领域:
- 肺病学和睡眠医学 睡眠医学
- 生物医学工程 生物医学工程
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 是一种常见的睡眠障碍,其特点是经常出现呼吸道阻塞.
- 间歇性缺氧 (IH) 和间歇性穿皮电刺激 (ITES) 是OSA的潜在治疗方式,但它们的联合作用尚不清楚.
研究的目的:
- 研究OSA患者联合IH和ITES的治疗价值.
- 为了比较IH,ITES及其组合 (IH&ITES) 与normoxia在减少OSA严重性的疗效.
主要方法:
- 一项前性,随机的,受控的交叉研究,涉及20名OSA参与者.
- 他们进行了四次单夜疗程:normoxia (控制),IH,ITES和IH&ITES.
- 主要终点是与normoxia相比,呼吸暂停-呼吸暂停指数 (AHI) 和氧气不和指数 (ODI) 的变化.
主要成果:
- 所有干预措施 (IH,ITES,IH&ITES) 与正常性相比显著降低了AHI (p<0.05).
- 与单独的IH相比,IH&ITES显示AHI的减少明显更大 (p=0.042).
- 对于轻度至中度的OSA,IH&ITES的疗效与ITES相当,但不优于ITES.
结论:
- IH,ITES和IH&ITES有效地减少了OSA的严重程度.
- 结合IH&ITES对轻度至中度的OSA比单独的IH更有效.
- 目前的数据不支持推IH&ITES而不是ITES用于OSA治疗.
相关概念视频
Sleep Apnea
143
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
143
Mechanical Ventilation III: Noninvasive Ventilation
97
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
Noninvasive Positive-Pressure Ventilation...
97
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
197
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
197
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
506
Oxygen therapy is a pivotal aspect of medical care, particularly for patients with respiratory ailments. Two prominent oxygen-delivering systems include the Venturi mask and the transtracheal oxygen catheter.
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
506
Acute Respiratory Failure-II
206
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
206


